Published in Lancet on February 10, 1973
The Oslo definitions for coeliac disease and related terms. Gut (2012) 5.76
Increased incidence of malignancy in dermatitis herpetiformis. Br Med J (Clin Res Ed) (1983) 1.45
The inhibition of polymorphonuclear leukocyte cytotoxicity by dapsone. A possible mechanism in the treatment of dermatitis herpetiformis. J Clin Invest (1978) 1.37
Tolerance to oats in dermatitis herpetiformis. Gut (1998) 1.19
The gluten-free diet and its current application in coeliac disease and dermatitis herpetiformis. United European Gastroenterol J (2015) 1.06
Coeliac disease and rheumatoid arthritis. Ann Rheum Dis (1984) 1.00
Coeliac disease and dermatitis herpetiformis: further studies of their relationship. Gut (1976) 0.99
Malignancy and survival in dermatitis herpetiformis: a comparison with coeliac disease. Gut (1996) 0.93
Dermatitis herpetiformis: effect of gluten-free diet on skin IgA and jejunal structure and function. Br Med J (1977) 0.92
Dermatitis herpetiformis: jejunal findings and skin response to gluten free diet. Arch Dis Child (1984) 0.92
Failure to detect specific gluten antigens associated with the immune aggregates in the skin in dermatitis herpetiformis. Arch Dermatol Res (1977) 0.90
Inflammatory cytokines in small intestinal mucosa of patients with potential coeliac disease. Clin Exp Immunol (2002) 0.90
Fc receptor function and circulating immune complexes in gluten sensitive enteropathy--possible significance of serum IgA. Gut (1991) 0.79
Response of the skin in dermatitis herpetiformis to a gluten free diet, with reference to jejunal morphology. Gut (1978) 0.79
Dermatitis herpetiformis: no evidence of bone disease despite evidence of enteropathy. Dig Dis Sci (2007) 0.78
Sequential studies of gliadin antibodies in patients with dermatitis herpetiformis. Arch Dermatol Res (1984) 0.78
Chronic gastritis in dermatitis herpetiformis: a controlled study. Clin Dev Immunol (2012) 0.76
Anti-gliadin antibodies in dermatitis herpetiformis. J R Soc Med (1981) 0.75
Gluten-sensitive dermatitis herpetiformis. Proc R Soc Med (1973) 0.75
Increased risk of lymphoma in dermatitis herpetiformis. J R Soc Med (1983) 0.75
Monozygous twins concordant for duodenojejunal villous atrophy and dermatitis herpetiformis. Gut (1986) 0.75
Dermatitis herpetiformis: pathophysiology, clinical presentation, diagnosis and treatment. An Bras Dermatol (2014) 0.75
Rapid improvement of dermatitis herpetiformis after elemental diet. Arch Dermatol Res (1981) 0.75
Ultrastructural localization of IgA deposits in adult linear IgA disease. J R Soc Med (1982) 0.75
Foods for patients with dermatitis herpetiformis. Can Med Assoc J (1983) 0.75
Dermatitis herpetiformis: relation between circulating immune complexes, small-intestinal mucosal status, and immunohistopathological findings. Arch Dermatol Res (1987) 0.75
A study of proximal and distal intestinal structure and absorptive function in idiopathic steatorrhoea. Q J Med (1967) 4.68
Method of assay of red cell folate activity and the value of the assay as a test for folate deficiency. J Clin Pathol (1966) 4.44
Tissue antibodies in dermatitis herpetiformis and adult coeliac disease. Lancet (1971) 3.50
Small-intestinal structure and function and haematological changes in dermatitis herpetiformis. Lancet (1967) 3.11
Epidermal T lymphocytes and HLA-DR expression in psoriasis. Br J Dermatol (1984) 2.93
Circulating immune complexes in dermatitis herpetiformis. Lancet (1973) 2.78
Anti-reticulin antibodies in childhood coeliac disease. Lancet (1971) 2.54
T-cell subpopulations in the blood and skin of patients with psoriasis. Br J Dermatol (1984) 2.54
Efficacy and possible adverse effects of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in thalassemia major. Blood (1992) 2.29
Folic acid fortification and cancer risk. Lancet (2007) 2.17
Antireticulin antibody: incidence and diagnostic significance. Gut (1973) 2.15
Lymphocytic infiltration of epithelium in diagnosis of gluten-sensitive enteropathy. Br Med J (1972) 2.11
Effect of gluten-free diet on dermatological, intestinal, and haematological manifestations of dermatitis herpetiformis. Lancet (1968) 2.09
Psoriasis: a T-cell-mediated autoimmune disease induced by streptococcal superantigens? Immunol Today (1995) 2.09
Ketoconazole versus nystatin plus amphotericin B for fungal prophylaxis in severely immunocompromised patients. Lancet (1982) 2.01
Parenteral acyclovir therapy for herpesvirus infections in man. Lancet (1979) 1.99
Absence of toxicity of oats in patients with dermatitis herpetiformis. N Engl J Med (1997) 1.98
The human thymic microenvironment: an immunohistologic study. J Immunol (1980) 1.94
Combined therapy with deferiprone and desferrioxamine. Br J Haematol (1998) 1.91
Agranulocytosis and thrombocytopenia in patient with Blackfan-Diamond anaemia during oral chelator trial. Lancet (1989) 1.91
Folate deficiency and neurological disease. Lancet (1965) 1.85
Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro. Br J Haematol (1996) 1.82
Subcutaneous infusion and intramuscular injection of desferrioxamine in patients with transfusional iron overload. Lancet (1976) 1.81
Clearance of psoriasis with low dose cyclosporin. Br Med J (Clin Res Ed) (1986) 1.75
Hypoparathyroidism and hypocalcaemia during treatment for acute leukaemia. Br Med J (Clin Res Ed) (1982) 1.72
Improvement in iron status and liver function in patients with transfusional iron overload with long-term subcutaneous desferrioxamine. Lancet (1979) 1.70
Dermatitis herpetiformis: an evaluation of diagnostic criteria. Br J Dermatol (1974) 1.66
Serum ferritin assay and iron status in chronic renal failure and haemodialysis. Br Med J (1975) 1.61
Gluten-free diet and reintroduction of gluten in dermatitis herpetiformis. Arch Dermatol (1969) 1.60
Deletion analysis of chromosome 13q14.3 and characterisation of an alternative splice form of LEU1 in B cell chronic lymphocytic leukemia. Leukemia (2002) 1.60
Bone-marrow aspiration and trephine biopsy (1). Br Med J (1980) 1.58
Psoriasis and streptococci: the natural selection of psoriasis revisited. Br J Dermatol (2009) 1.58
Mechanism of folate deficiency in patients receiving phenytoin. Lancet (1968) 1.58
Expression of interferon-gamma receptors in normal and psoriatic skin. J Invest Dermatol (1992) 1.57
Binding of wheat gliadin in vitro to reticulum in normal and dermatitis herpetiformis skin. J Invest Dermatol (1981) 1.57
Long term follow-up of dermatitis herpetiformis with and without dietary gluten withdrawal. Br J Dermatol (1982) 1.56
Normal keratinocytes express Toll-like receptors (TLRs) 1, 2 and 5: modulation of TLR expression in chronic plaque psoriasis. Br J Dermatol (2003) 1.56
Use of anti-T-cell monoclonal antibody OKT3 to prevent acute graft-versus-host disease in allogeneic bone-marrow transplantation for acute leukaemia. Lancet (1982) 1.55
The hematologic complications following partial gastrectomy. A study of 292 patients. Am J Med (1967) 1.55
The small intestine in dermatitis herpetiformis. J Clin Pathol (1974) 1.54
Hepatic iron concentration combined with long-term monitoring of serum ferritin to predict complications of iron overload in thalassaemia major. Br J Haematol (2000) 1.54
Immunoglobulins in the skin in dermatitis herpetiformis and coeliac disease. Lancet (1972) 1.53
Unusual megaloblastic anaemia wiht multinucleate erythroblasts: two cases with septicaemia and acute renal failure. J Clin Pathol (1975) 1.53
The effects of cyclosporin A on T lymphocyte and dendritic cell sub-populations in psoriasis. Br J Dermatol (1987) 1.53
Subpopulations of normal and leukemic human thymocytes: an analysis with the use of monoclonal antibodies. J Natl Cancer Inst (1980) 1.50
Increased incidence of malignancy in dermatitis herpetiformis. Br Med J (Clin Res Ed) (1983) 1.45
Increased numbers of cells with suppressor T cell phenotype in the peripheral blood of patients with infectious mononucleosis. Clin Exp Immunol (1981) 1.45
Multiple immune complexes and hypocomplementaemia in dermatitis herpetiformis and coeliac disease. Lancet (1976) 1.45
Use of cyclosporin in psoriasis. Lancet (1990) 1.43
Iron chelation therapy: the need for orally active drugs. J Lab Clin Med (1998) 1.42
Long-term cyclosporin for psoriasis. Br J Dermatol (1989) 1.42
Human B cell development. I. Phenotypic differences of B lymphocytes in the bone marrow and peripheral lymphoid tissue. J Immunol (1985) 1.41
Serum immunoreactive trypsin in beta-thalassaemia major. J Clin Pathol (1981) 1.41
Stomatococcus mucilaginosus: an emerging pathogen in neutropenic patients. Clin Infect Dis (1992) 1.39
Cytotoxicity of wound dressing materials assessed using cultured skin equivalents. Burns (1995) 1.39
Cyclosporin toxicity. Lancet (1990) 1.38
Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: randomised double blind trial. Br Med J (Clin Res Ed) (1983) 1.37
Anti-gliadin antibodies and small intestinal mucosal damage in dermatitis herpetiformis. Br J Dermatol (1981) 1.35
Absorption of crystalline folic acid in man. Lancet (1968) 1.35
Tumour necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies. Lancet (1988) 1.35
Folate deficiency in Crohn's disease: incidence, pathogenesis, and treatment. Br Med J (1968) 1.34
Multiparameter studies in lymphoid leukemias. Am J Clin Pathol (1979) 1.34
Rubella, 1962. Br Med J (1962) 1.33
Folate deficiency in premature infants. Arch Dis Child (1970) 1.33
Iron and folate metabolism in tuberculosis. Br Med J (1966) 1.33
Immunoglobulins in the skin in dermatitis herpetiformis and their relevance in diagnosis. Br J Dermatol (1975) 1.32
Orally active alpha-ketohydroxy pyridine iron chelators intended for clinical use: in vivo studies in rabbits. Br J Haematol (1986) 1.31
Effect of iron deficiency and desferrioxamine on DNA synthesis in human cells. Br J Haematol (1976) 1.30
High incidence of cardiomyopathy in beta-thalassaemia patients receiving regular transfusion and iron chelation: reversal by intensified chelation. Acta Haematol (1990) 1.30
Transfer of a functioning humoral immune system in transplantation of T-lymphocyte-depleted bone marrow. Lancet (1986) 1.29
Remission induction with adenosine-deaminase inhibitor 2'-deoxycoformycin in Thy-lymphoblastic leukaemia. Lancet (1980) 1.29
Epidermal T lymphocytes and dendritic cells in chronic plaque psoriasis: the effects of PUVA treatment. Clin Exp Immunol (1985) 1.29
Gluten challenge in dermatitis herpetiformis. N Engl J Med (1983) 1.28
Streptococcus mitis and ARDS in neutropenic patients. Lancet (1991) 1.28
Effective chelation of iron in beta thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one. Br Med J (Clin Res Ed) (1987) 1.28
Mechanisms of resistance of human acute leukaemia cells to cytosine arabinoside. Br J Haematol (1974) 1.28
Evidence that a locus for familial psoriasis maps to chromosome 4q. Nat Genet (1996) 1.27
Splenic atrophy in dermatitis herpetiformis. Br Med J (1972) 1.25